# Debate Matchup Judgment Report

**GPT-5.4 (no reasoning)** vs **Mistral Large 3**

- Paired result: **GPT-5.4 (no reasoning)**
- Mean entertainment: `6.88 / 10`
- Judge decisions: `8` across two side-swapped debates

**Motion:** Health systems should permit and reimburse AI-assisted clinical documentation and triage only if models meet publicly reported accuracy and bias benchmarks.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0624__gpt-5.4-none__mistral-large-2512__s0__tpl_placement_active_20260320f.md): PRO = **GPT-5.4 (no reasoning)**, CON = **Mistral Large 3**
- [Debate B transcript](../../../transcripts/prop_0624__mistral-large-2512__gpt-5.4-none__s1__tpl_placement_active_20260320f.md): PRO = **Mistral Large 3**, CON = **GPT-5.4 (no reasoning)**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_20260814a.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0624__gpt-5.4-none__mistral-large-2512__s0__tpl_placement_active_20260320f.md)
- Roles: PRO = **GPT-5.4 (no reasoning)**, CON = **Mistral Large 3**
- Judged result: Unanimous `4-0` for **GPT-5.4 (no reasoning)**.
- Entertainment scores: `7`, `6`, `7`, `7`
- Mean signed raw margin (PRO+): `+1.80`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = Mistral Large 3 (CON); B = GPT-5.4 (no reasoning) (PRO) | GPT-5.4 (no reasoning) | +2.6 | +2.17 | 7.0 |
| Grok 4.3 | A = GPT-5.4 (no reasoning) (PRO); B = Mistral Large 3 (CON) | GPT-5.4 (no reasoning) | +1.5 | +1.80 | 6.0 |
| Kimi K2.6 | A = GPT-5.4 (no reasoning) (PRO); B = Mistral Large 3 (CON) | GPT-5.4 (no reasoning) | +1.6 | +1.60 | 7.0 |
| Qwen 3.6 Max Preview | A = Mistral Large 3 (CON); B = GPT-5.4 (no reasoning) (PRO) | GPT-5.4 (no reasoning) | +1.5 | +1.50 | 7.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = Mistral Large 3 (CON); B = GPT-5.4 (no reasoning) (PRO)): Side B wins by maintaining a consistent, well-reasoned stance that public benchmarks are a necessary safety floor. Side A makes solid initial points about the need for local context and post-market surveillance, but suffers a severe persona collapse in the Pressure Questions round, where it accidentally attacks its own position. Side B capitalizes on this flawlessly.
  Most decisive rebuttal noted: Side B's Rebuttal 1 neatly flips Side A's "moving field" argument by pointing out that if models drift, it makes baseline public reporting more necessary, not less.
- **Grok 4.3** (A = GPT-5.4 (no reasoning) (PRO); B = Mistral Large 3 (CON)): Side A built the stronger case by consistently defending the need for public benchmarks on safety, fairness, and incentives grounds, directly answering pressure questions in Rebuttal 2, and crystallizing the comparison between scaled opaque harm versus slower deployment. Side B's openings and rebuttals were clipped (execution cost), offered weaker responses to core risks, and replaced benchmarks with less transparent alternatives without neutralizing A's weighing.
  Most decisive rebuttal noted: Side A's Rebuttal 2 (A1/A2 answers plus weighing) directly engaged B's pilot claims and exposed the transparency deficit.
- **Kimi K2.6** (A = GPT-5.4 (no reasoning) (PRO); B = Mistral Large 3 (CON)): Side A won by demonstrating that the CON alternative of ungated pilots and post-market surveillance effectively treats patients as beta testers in scaled, reimbursed clinical infrastructure, while failing to protect smaller health systems from vendor marketing capture. A successfully turned several CON arguments—showing that dynamic clinical environments require recurring transparent benchmarks rather than no gates, and that local adaptation actually demands public baseline floors for meaningful comparison. CON's strongest points about gaming benchmarks and regulatory capture were partially mitigated by A's emphasis on publicly reported scrutiny enabling ongoing comparison rather than one-time box-checking, and CON's informed-consent pilot model strained plausibility for routine operational deployment in ordinary care.
  Most decisive rebuttal noted: The exchange over whether "pilot and iterate" avoids patient harm: A showed that reimbursed documentation and triage are not sandboxed experiments because a bad note contaminates charts and a bad triage ranking delays care at scale, while B's response that pilots include informed consent and compensation created an unrealistic framing of routine clinical operations that A crystallized as "delayed discovery of preventable harm."
- **Qwen 3.6 Max Preview** (A = Mistral Large 3 (CON); B = GPT-5.4 (no reasoning) (PRO)): Side B wins by successfully framing reimbursement as a trigger for scaled deployment, making ex ante public benchmarks a necessary floor rather than a bureaucratic ceiling. B effectively turned A’s context and drift arguments into reasons for recurring transparent measurement, and won the equity clash by showing how public benchmarks protect smaller hospitals from vendor marketing, whereas A’s pilot model favors well-resourced systems. A’s alternative relied on an idealized pilot structure with informed consent and independent audits that functionally resembled benchmarks but lacked the motion’s transparency requirement. B’s weighing on “scale changes the ethics” and cleaner handling of pressure questions secured the win.
  Most decisive rebuttal noted: B’s response to A’s “benchmarks are static and context-dependent” claim, arguing that drift and local variation make recurring public reporting more necessary, not less, while framing benchmarks as a comparative floor that enables honest local validation rather than replacing it.

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0624__mistral-large-2512__gpt-5.4-none__s1__tpl_placement_active_20260320f.md)
- Roles: PRO = **Mistral Large 3**, CON = **GPT-5.4 (no reasoning)**
- Judged result: Split `2-2`.
- Entertainment scores: `8`, `6`, `7`, `7`
- Mean signed raw margin (PRO+): `-0.15`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = GPT-5.4 (no reasoning) (CON); B = Mistral Large 3 (PRO) | GPT-5.4 (no reasoning) | -1.5 | -1.25 | 8.0 |
| Grok 4.3 | A = Mistral Large 3 (PRO); B = GPT-5.4 (no reasoning) (CON) | Mistral Large 3 | +1.5 | +1.80 | 6.0 |
| Kimi K2.6 | A = Mistral Large 3 (PRO); B = GPT-5.4 (no reasoning) (CON) | Mistral Large 3 | +0.9 | +0.90 | 7.0 |
| Qwen 3.6 Max Preview | A = GPT-5.4 (no reasoning) (CON); B = Mistral Large 3 (PRO) | GPT-5.4 (no reasoning) | -1.5 | -1.50 | 7.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = GPT-5.4 (no reasoning) (CON); B = Mistral Large 3 (PRO)): Side A systematically dismantled Side B's defense of the 'only if' mechanism, particularly by differentiating the risks of documentation scribes versus triage. While Side B provided strong examples of local validation failing, Side A successfully weaponized Side B's pressure question answers to prove the proposition would ban net-beneficial tools while administrators debated metric design.
  Most decisive rebuttal noted: Side A's second rebuttal, which capitalized on Side B's pressure question answers to expose the functional reality of the proposition: waiting for a benchmark means keeping patients in backlogs.
- **Grok 4.3** (A = Mistral Large 3 (PRO); B = GPT-5.4 (no reasoning) (CON)): Side A wins by directly answering pressure questions with concrete examples of local-audit failures and sustaining the accountability comparison through rebuttals and closing. Side B’s risk-proportionate alternative is never shown to reliably catch the documented bias cases A cites.
  Most decisive rebuttal noted: A’s Rebuttal 2 (A1/A2) squarely addresses B’s questions on benchmark setters and local trade-offs, using prior examples to damage B’s local-validation route.
- **Kimi K2.6** (A = Mistral Large 3 (PRO); B = GPT-5.4 (no reasoning) (CON)): PRO wins narrowly by grounding the debate in concrete, documented patterns of harm from unbenchmarked AI tools and delivering sharper, more direct answers to pressure questions. While CON effectively exposed textual tension in the "only if" phrasing and raised legitimate concerns about rigidity, they relied more on hypothetical blocked benefits and abstract procedural objections. PRO's real-world examples of algorithmic bias causing patient harm, combined with their clean rebuttal that a locally "better" tool missing bias benchmarks is merely "faster at replicating inequities," proved harder to neutralize and provided the decisive comparative edge.
  Most decisive rebuttal noted: PRO's Rebuttal 2 response that a triage tool beating the current nurse backlog while missing a public bias cutoff is not "safer" but rather "faster at replicating inequities," which directly collapsed CON's core status-quo-comparison argument.
- **Qwen 3.6 Max Preview** (A = GPT-5.4 (no reasoning) (CON); B = Mistral Large 3 (PRO)): CON wins by successfully framing the motion's "only if" clause as a rigid gate that inevitably delays or denies net-beneficial tools in a strained healthcare system. While PRO built a morally compelling case for transparency and cited real-world AI bias failures, CON's pressure questions forced PRO to concede that tools would be blocked pending benchmark development or denied if they missed arbitrary cutoffs despite local utility. CON's comparative weighing—contrasting PRO's metric formalism with risk-proportionate, clinician-supervised deployment—proved more persuasive and practically grounded. PRO's repeated reliance on past AI failures never fully answered CON's core point that layered local oversight, not a universal public scoreboard, is the appropriate safety mechanism for varied clinical workflows.
  Most decisive rebuttal noted: The exchange over CON's Q1/Q2 in Rebuttal 2 was decisive. PRO's admission that missing a public benchmark means denying reimbursement ("fix the underlying system" rather than deploy a locally superior tool) handed CON a clear comparative advantage. CON immediately leveraged this in A4.4-A4.6 to crystallize the tradeoff: PRO's rule sacrifices real patients in current backlogs to satisfy abstract metric availability, making CON's risk-based alternative the more responsible path.

## Technical metadata

- Evaluation scope: `judge_judge_blend_20260814a__debate_all_templates`
- Topic ID: `prop_0624`
- Side-swap group ID: `prop_0624__gpt-5.4-none__mistral-large-2512__tpl_placement_active_20260320f`
- Raw paired winner: **GPT-5.4 (no reasoning)**
- Mean normalized margin for GPT-5.4 (no reasoning): `+0.89`
- Complete side swap: `yes`
- Included in ratings: `yes`
